Sanofi-Aventis Deutschland Gmbh
🇸🇪Sweden
- Country
- 🇸🇪Sweden
- Ownership
- Subsidiary
- Established
- 1863-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.sanofi-aventis.de
Clinical Trials
14
Active:10
Completed:4
Trial Phases
2 Phases
Phase 1:3
Not Applicable:4
Drug Approvals
43
NMPA:38
EMA:5
Drug Approvals
Sodium Valproate for Injection
- Product Name
- 德巴金
- Approval Number
- 国药准字HJ20150085
- Approval Date
- Jul 10, 2024
NMPA
Sodium Valproate for Injection
- Product Name
- 德巴金
- Approval Number
- 国药准字HJ20150084
- Approval Date
- Jul 10, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials
Not Applicable
4 (57.1%)Phase 1
3 (42.9%)No trials found
News
No news found